
Australia's Illuccix receives approval for prostate cancer imaging in Brazil
Australia's Illuccix receives approval for prostate cancer imaging in Brazil March 19, 2025 | Wednesday | News First marketing authorisation in Latin America Australia-based Telix Pharmaceuticals has announced that the Brazilian Health Regulatory …